Keros Therapeutics

Keros Therapeutics: A leader in understanding the role of the Transforming Growth Factor-Beta family of proteins that is a master regulator of red blood cell and platelet production as well as the growth, repair and maintenance of muscle and bone. Lead protein therapeutic product candidate, KER-050, is being developed for the treatment of cytopenias, including anemia and thrombocytopenia, in patients with myelodysplastic syndrome (MDS) and myelofibrosis, with additional data from Part 1 of Ph 2 study in MDS being presented at ASH 2021. Lead small molecule product candidate, KER-047, is being developed for the treatment of anemia resulting from elevated levels of hepcidin, the key regulator of iron absorption and recycling, as well as for the treatment of fibrodysplasia ossificans progressiva.
Based in...
US - New England
Clinical Stage
Phase l or ll
Disease Space
Hematology, Metabolic Disorders, Oncology, Rare Disease
Public, USA
Market Cap
500MM - 1B
99 Hayden Avenue
Suite 120 (Building E)
Lexington, MA 02421
United States

Company Participants at Solebury Trout 1x1 Management Access Event 2022

  • Jasbir Seehra, CEO

Top 10 Holders of Keros Therapeutics, Inc.

Institution OS (%) Position Mkt Val ($MM) Source Filing Date
Fidelity Management & Research Co. LLC 12.53 3,007,639 110.89 13F 3/31/22
OrbiMed Advisors LLC 7.00 1,679,417 61.92 13F 3/31/22
Deep Track Capital LP 5.75 1,380,306 50.89 13F 3/31/22
Nantahala Capital Management LLC 3.40 816,830 30.12 13F 3/31/22
Alkeon Capital Management LLC (13F Subfiler) 3.24 777,114 28.65 13F 3/31/22
The Vanguard Group, Inc. 3.07 734,695 27.09 Funds 4/30/22
Vanguard Group, Inc. (Subfiler) 2.92 699,814 25.80 13F 3/31/22
State Street Corp. 2.85 683,647 25.21 13F 3/31/22
BlackRock Fund Advisors 2.76 662,023 24.41 13F 3/31/22
First Light Asset Management LLC 2.74 658,145 24.27 13F 3/31/22
Ownership data is sourced through FactSet.

Stock Market Data

Data is being loaded...
Data is being loaded...
Data is being loaded...
Data is being loaded...
Market Data copyright © 2022 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, RTB=Real-Time BATS BZX Price/Quote; not sourced from all markets, RTN=Real-Time NASDAQ Basic+ Price/Quote; not sourced from all markets, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.